台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    77.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.65%
  • 成交量
    191
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-兆豐-城中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-城中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/17176.5000.0076.5011930.52%
2025/01/1400.000.376.0076.30-0.3194-0.15%
2024/12/260.176.800.377.5077.80-0.2183-0.11%
2024/12/230.376.5000.0076.200.31720.15%
2024/12/0500.00278.5078.00-2140-1.42%
2024/12/0200.00278.5078.50-2137-1.46%
2024/11/2200.00582.0082.00-5121-4.10%
2024/11/2100.002.177.0079.40-2.1108-1.97%
2024/10/29277.8000.0077.8021231.62%
2024/10/28378.4700.0078.0031262.37%
2024/10/2400.001.178.9378.80-1.1135-0.81%
2024/08/14278.2000.0078.4022950.68%
2024/08/05274.700.272.1072.501.92990.62%
2024/08/02579.6000.0079.5052911.71%
2024/08/01179.9000.0080.4012900.34%
2024/07/31379.5000.0080.0032961.01%
2024/07/30379.2000.0080.4032931.02%
2024/07/29180.7000.0079.5012890.35%
2024/07/080.184.5000.0084.200.12800.04%
2024/07/0500.000.585.4084.70-0.5278-0.17%
2024/07/0100.000.384.6684.50-0.3272-0.12%
2024/06/28183.1000.0083.5012700.37%
2024/06/27183.2000.0083.5012690.37%
2024/06/25381.9300.0083.5032601.15%
2024/06/241492.8100.0089.20142385.87%
2024/06/190.198.9000.0098.000.12240.04%
2024/06/1800.00198.5098.50-1221-0.45%
2024/06/170.398.9000.0098.700.32200.14%
2024/06/11496.9500.0097.4042231.79%
2024/06/07295.900.299.5599.601.82200.82%
2024/06/05296.0000.0097.0022060.97%
2024/05/2800.00195.2095.90-1239-0.42%
2024/05/20194.20294.5094.70-1270-0.37%
2024/05/14193.4000.0093.8013230.31%
2024/05/13294.0500.0094.1023240.62%
2024/04/290.196.4000.0095.500.13190.03%
2024/04/2200.00194.1094.00-1331-0.30%
2024/04/19394.4700.0093.6033390.88%
2024/04/18297.2500.0097.0023290.61%
2024/04/1600.00296.0096.80-2334-0.60%
2024/04/1500.00198.3098.30-1331-0.30%
2024/04/1000.000.2100.0099.40-0.2330-0.06%
2024/04/03197.9000.0098.0013280.30%
2024/04/02298.40099.0098.0023300.60%
2024/03/28197.6000.0097.8013430.29%
2024/03/26196.8000.0096.6013640.27%
2024/03/2500.00196.9096.90-1372-0.27%
2024/03/1400.00195.1095.10-1371-0.27%
2024/03/13196.0000.0095.7013700.27%
2024/03/11194.8000.0095.5013700.27%
2024/03/051.1100.6800.00100.501.13550.31%
2024/03/041103.0000.00102.0013490.29%
2024/02/272101.0000.00103.5023420.58%
2024/02/221.1101.550.3102.00102.000.83520.23%
2024/02/211103.0000.00104.0013480.29%
2024/02/190.1100.001.4105.96107.00-1.3322-0.39%
2024/02/160.197.1000.0097.800.12880.03%
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-18天前
逸達營收/去年4.2億、年增115% 今年拚歐、美、中新藥藥證UDN聯合新聞網-23天前
逸達進軍歐盟 首批前列腺癌新劑型新藥正式出貨Anue鉅亨-2024/12/18
逸達 相關文章
逸達 相關影音